Roles of NF-κB in Cancer and Their Therapeutic Approaches / / edited by Véronique Baud.
Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broad...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2018. |
Year of Publication: | 2018 |
Language: | English |
Physical Description: | 1 online resource (x, 330 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993603259104498 |
---|---|
ctrlnum |
(CKB)5400000000000203 (NjHacI)995400000000000203 (EXLCZ)995400000000000203 |
collection |
bib_alma |
record_format |
marc |
spelling |
Roles of NF-κB in Cancer and Their Therapeutic Approaches / edited by Véronique Baud. Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2018. 1 online resource (x, 330 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broadly-active anticancer drugs have a small therapeutic index and barely discriminate between malignant and normal cells. In recent years the focus has shifted to the development of rationally designed, molecularly-targeted therapy for the treatment of a specific cancer, therefore offering the promise of greater specificity coupled with reduced systemic toxicity. NF-kB transcription factor family as emerged as such a promising target for cancer therapy. This Special Issue will explore the routes from NF-kB basic research, cancer research and oncogenomics into the development of NF-kB-based cancer therapeutics and biomarkers. We invite research and review papers in any area of the NF-kB field that are related, but not limited to, fundamental understanding of NF-kB signaling pathways, gene expression profiling, epigenetic regulation, diagnostic, prognostic and pharmacogenomic biomarkers, molecular targets driving the progression of human cancers, cancer drug development on these targets, clinical trial with new agents, and validation in animal models. We hope that this Special Issue reflects the exciting era that we are living in with respect to the field of NF-kB and its applications in cancer research. Transcription factors. Proteins Therapeutic use. Baud, Véronique, editor. |
language |
English |
format |
eBook |
author2 |
Baud, Véronique, |
author_facet |
Baud, Véronique, |
author2_variant |
v b vb |
author2_role |
TeilnehmendeR |
title |
Roles of NF-κB in Cancer and Their Therapeutic Approaches / |
spellingShingle |
Roles of NF-κB in Cancer and Their Therapeutic Approaches / |
title_full |
Roles of NF-κB in Cancer and Their Therapeutic Approaches / edited by Véronique Baud. |
title_fullStr |
Roles of NF-κB in Cancer and Their Therapeutic Approaches / edited by Véronique Baud. |
title_full_unstemmed |
Roles of NF-κB in Cancer and Their Therapeutic Approaches / edited by Véronique Baud. |
title_auth |
Roles of NF-κB in Cancer and Their Therapeutic Approaches / |
title_new |
Roles of NF-κB in Cancer and Their Therapeutic Approaches / |
title_sort |
roles of nf-κb in cancer and their therapeutic approaches / |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2018 |
physical |
1 online resource (x, 330 pages) |
isbn |
3-03897-118-9 |
callnumber-first |
Q - Science |
callnumber-subject |
QP - Physiology |
callnumber-label |
QP552 |
callnumber-sort |
QP 3552 T68 R654 42018 |
illustrated |
Not Illustrated |
dewey-hundreds |
500 - Science |
dewey-tens |
570 - Life sciences; biology |
dewey-ones |
572 - Biochemistry |
dewey-full |
572.8845 |
dewey-sort |
3572.8845 |
dewey-raw |
572.8845 |
dewey-search |
572.8845 |
work_keys_str_mv |
AT baudveronique rolesofnfkbincancerandtheirtherapeuticapproaches |
status_str |
n |
ids_txt_mv |
(CKB)5400000000000203 (NjHacI)995400000000000203 (EXLCZ)995400000000000203 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Roles of NF-κB in Cancer and Their Therapeutic Approaches / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796653202253283328 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02502nam a2200289 i 4500</leader><controlfield tag="001">993603259104498</controlfield><controlfield tag="005">20230702121208.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230702s2018 sz o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03897-118-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000000203</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000000203</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000000203</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QP552.T68</subfield><subfield code="b">.R654 2018</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">572.8845</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Roles of NF-κB in Cancer and Their Therapeutic Approaches /</subfield><subfield code="c">edited by Véronique Baud.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2018.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (x, 330 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broadly-active anticancer drugs have a small therapeutic index and barely discriminate between malignant and normal cells. In recent years the focus has shifted to the development of rationally designed, molecularly-targeted therapy for the treatment of a specific cancer, therefore offering the promise of greater specificity coupled with reduced systemic toxicity. NF-kB transcription factor family as emerged as such a promising target for cancer therapy. This Special Issue will explore the routes from NF-kB basic research, cancer research and oncogenomics into the development of NF-kB-based cancer therapeutics and biomarkers. We invite research and review papers in any area of the NF-kB field that are related, but not limited to, fundamental understanding of NF-kB signaling pathways, gene expression profiling, epigenetic regulation, diagnostic, prognostic and pharmacogenomic biomarkers, molecular targets driving the progression of human cancers, cancer drug development on these targets, clinical trial with new agents, and validation in animal models. We hope that this Special Issue reflects the exciting era that we are living in with respect to the field of NF-kB and its applications in cancer research.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Transcription factors.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Proteins</subfield><subfield code="x">Therapeutic use.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baud, Véronique,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:18:29 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-10-31 22:37:04 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345719570004498&Force_direct=true</subfield><subfield code="Z">5345719570004498</subfield><subfield code="b">Available</subfield><subfield code="8">5345719570004498</subfield></datafield></record></collection> |